Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
November 16 2021 - 12:45PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check
one):
|
☐ Form 10-K ☐ Form 20-F ☐
Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR
☐ Form N-CSR
|
For
Period Ended: September 30, 2021
|
☐
|
Transition
Report on Form 10-K
|
|
☐
|
Transition
Report on Form 20-F
|
|
☐
|
Transition
Report on Form 11-K
|
|
☐
|
Transition
Report on Form 10-Q
|
|
☐
|
Transition
Report on Form N-SAR
|
For
the Transition Period Ended: ______________________________________________________________
Read
Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
|
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
_____________________________________________________________________________________________
PART
I — REGISTRANT INFORMATION
Balance
Labs, Inc.
Full
Name of Registrant
Former
Name if Applicable
407
Lincoln Road, Suite 701
Address
of Principal Executive Office (Street and Number)
Miami
Beach, Florida 33139
City,
State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate)
|
(a)
|
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
☒
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
(c)
|
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III — NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not
be filed within the prescribed time period.
The
compilation, dissemination and review of the information required to be presented in the Form 10-Q for the fiscal quarter ended June
30, 2021 has imposed requirements that have rendered timely filing of the Form 10-Q impracticable without undue hardship and expense
to the registrant.
PART
IV — OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this notification
Michael Farkas
|
|
(305)
|
|
907-7600
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed ? If answer is no, identify report(s). Yes ☒ No ☐
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion thereof?
Yes
☒ No ☐
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.
The
Company reported net loss for three and nine months ended September 30, 2020, whereas the Company will be reporting a net income for
the same periods this year. The difference between these results is primarily due to an increase in the value of an investment.
BALANCE
LABS, INC.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
|
BALANCE
LABS, INC.
|
|
|
|
Date:
November 16, 2021
|
By :
|
/s/
Michael Farkas
|
|
|
Michael
Farkas
|
|
|
Chief
Executive Officer and
|
|
|
Chief
Financial Officer
|
Balance Labs (PK) (USOTC:BLNC)
Historical Stock Chart
From Nov 2024 to Dec 2024
Balance Labs (PK) (USOTC:BLNC)
Historical Stock Chart
From Dec 2023 to Dec 2024